Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Market - Pipeline Review Report H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Peripheral Nerve Sheath Tumor, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Nerve Sheath Tumor and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Peripheral Nerve Sheath Tumor Overview
  3. Therapeutics Development
  4. Pipeline Products for Peripheral Nerve Sheath Tumor - Overview
  5. Pipeline Products for Peripheral Nerve Sheath Tumor - Comparative Analysis
  6. Peripheral Nerve Sheath Tumor - Therapeutics under Development by Companies
  7. Peripheral Nerve Sheath Tumor - Therapeutics under Investigation by Universities/Institutes
  8. Peripheral Nerve Sheath Tumor Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Peripheral Nerve Sheath Tumor - Products under Development by Companies
  13. Peripheral Nerve Sheath Tumor - Products under Investigation by Universities/Institutes
  14. Peripheral Nerve Sheath Tumor - Companies Involved in Therapeutics Development
  • Bexion Pharmaceuticals, LLC.
  • EpiZyme, Inc.
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • Novartis AG
  • Plexxikon Inc.
  • Synta Pharmaceuticals Corp.
  • Vyriad

For more information about this report visit http://www.researchandmarkets.com/research/jgbj6q/peripheral_nerve

Related Topics: Oncology Drugs , Brain Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716